Federated Hermes’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-10,000
Closed -$1.86M 2172
2017
Q3
$1.86M Sell
10,000
-4,000
-29% -$709K 0.01% 955
2017
Q2
$2.41M Hold
14,000
0.01% 830
2017
Q1
$2.3M Sell
14,000
-6,000
-30% -$997K 0.01% 854
2016
Q4
$2.87M Buy
+20,000
New +$3.01M 0.01% 736

Other funds holding AMGN

Federated Hermes's AMGN Position: Q2 2026 in Review

Federated Hermes increased its Amgen (AMGN) stake by 21% in Q2 2026, buying an estimated $80.8M and bringing the position to 1,372,553 shares worth $497M. The position accounts for 0.71% of the portfolio, ranked #22.

Federated Hermes first reported a position in AMGN in Q2 2013 and has held it in 53 quarters since. The position peaked at $672M in Q3 2023. 3,153 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Federated Hermes held 1,372,553 shares of Amgen worth $497M as of Q2 2026.
  • Federated Hermes bought 236,035 Amgen shares in Q2 2026, an estimated $80.8M.
  • Amgen made up 0.71% of Federated Hermes's portfolio in Q2 2026, its #22 holding.
  • Federated Hermes first reported a position in Amgen in Q2 2013 and has held it in 53 quarters since.
  • Federated Hermes's Amgen position peaked at $672M in Q3 2023.
  • 3,153 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Federated Hermes's 13F filing for Q2 2026, filed 12 Aug 2026.